Energene Biologicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 M
as on 03-01-2025
- Revenue -50.44%
(FY 2022)
- Profit -99.63%
(FY 2022)
- Ebitda -23.12%
(FY 2022)
- Net Worth 0.12%
(FY 2022)
- Total Assets -16.36%
(FY 2022)
About Energene Biologicals
The Corporate was formerly known as Irman Life Care Private Limited. The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Muhammed Irfan and Muhammed Manzer serve as directors at the Company.
- CIN/LLPIN
U24304AP2017PTC106774
- Company No.
106774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Energene Biologicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muhammed Irfan  | Director | 29-Sep-2017 | Current |
| Muhammed Manzer | Director | 29-Sep-2017 | Current |
Financial Performance of Energene Biologicals.
Energene Biologicals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 50.44% decrease. The company also saw a substantial fall in profitability, with a 99.63% decrease in profit. The company's net worth moved up by a moderate rise of 0.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Energene Biologicals?
Unlock access to Energene Biologicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 14 Sep 2021 | ₹1.00 M | Satisfied |
How Many Employees Work at Energene Biologicals?
Unlock and access historical data on people associated with Energene Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Energene Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Energene Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
